DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator ...
- Latest
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator ...
New Delhi, Aug 26: The Government of India will soon launch a special incentives scheme to support 75 start-ups in ...
New Delhi: There are about 2.68 crore people with disabilities in India. About 20% of them have difficulty in movement ...
© 2022 Mharo Rajasthan
